Literature DB >> 6827528

Analogues of aminoglutethimide: selective inhibition of cholesterol side-chain cleavage.

A B Foster, M Jarman, C S Leung, M G Rowlands, G N Taylor.   

Abstract

In our probing of the structural features responsible for the inhibitory activity of aminoglutethimide [1, 3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione] toward the cholesterol side-chain cleavage enzyme system desmolase and the estrogen-forming system aromatase, targets in the action of 1 against hormone-dependent mammary tumors, analogues in several categories have been synthesized and evaluated. Of the known monoamino derivatives, the meta derivative [2, 3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione] was as inhibitory toward desmolase as 1, and the N-amino analogue [4, 1-amino-3-ethyl-3-phenylpiperidine-2,6-dione] was three times as inhibitory (respective Ki values of 1, 2, and 4 are 14, 13, and 4.6 microM), but 2 was a weak inhibitor and 4 was a noninhibitor of aromatase. Another amino analogue [5, 5-amino-3-ethyl-3-phenylpiperidine-2,6-dione] inhibited neither enzyme system. Reaction of glutethimide (11) with hydrazine and thermal cyclization of the resulting amide hydrazide (15) afforded an improved synthesis of 4. Analogues having a second amino substituent, either at C-5 (10) or at N-1 (14) of the piperidine-2,6-dione residue, were less inhibitory than was 1 toward desmolase and aromatase. Among analogues having little or no inhibitory activity were hydroxy derivatives of 1 and 2, namely, 3-(4-amino-3-hydroxyphenyl)-3-ethylpiperidine-2,6-dione (20) and the 3-amino-4-hydroxy analogue (21).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6827528     DOI: 10.1021/jm00355a011

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Clinical pharmacology of aminoglutethimide in patients with metastatic breast cancer.

Authors:  A A Miller; B E Miller; K Höffken; C G Schmidt
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Single-dose and steady-state pharmacokinetics of aminoglutethimide.

Authors:  P E Lønning; J S Schanche; S Kvinnsland; P M Ueland
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

3.  Assessment of chemical effects on aromatase activity using the H295R cell line.

Authors:  Eric B Higley; John L Newsted; Xiaowei Zhang; John P Giesy; Markus Hecker
Journal:  Environ Sci Pollut Res Int       Date:  2010-01-20       Impact factor: 4.223

4.  The effect of acetylator phenotype on the disposition of aminoglutethimide.

Authors:  A M Adam; H J Rogers; S A Amiel; R D Rubens
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

5.  Aminoglutethimide prevents excitotoxic and ischemic injuries in cortical neurons.

Authors:  Hisashi Shirakawa; Hiroshi Katsuki; Toshiaki Kume; Shuji Kaneko; Akinori Akaike
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

6.  Pregnenolone can protect the brain from cannabis intoxication.

Authors:  Monique Vallée; Sergio Vitiello; Luigi Bellocchio; Etienne Hébert-Chatelain; Stéphanie Monlezun; Elena Martin-Garcia; Fernando Kasanetz; Gemma L Baillie; Francesca Panin; Adeline Cathala; Valérie Roullot-Lacarrière; Sandy Fabre; Dow P Hurst; Diane L Lynch; Derek M Shore; Véronique Deroche-Gamonet; Umberto Spampinato; Jean-Michel Revest; Rafael Maldonado; Patricia H Reggio; Ruth A Ross; Giovanni Marsicano; Pier Vincenzo Piazza
Journal:  Science       Date:  2014-01-03       Impact factor: 47.728

7.  The Elbs and Boyland-Sims peroxydisulfate oxidations.

Authors:  E J Behrman
Journal:  Beilstein J Org Chem       Date:  2006-11-07       Impact factor: 2.883

8.  Metabolism of aminoglutethimide in humans: quantification and clinical relevance of induced metabolism.

Authors:  P E Goss; M Jarman; L J Griggs
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

9.  The effects of the standardized extracts of Ginkgo biloba on steroidogenesis pathways and aromatase activity in H295R human adrenocortical carcinoma cells.

Authors:  Mijie Kim; Yong Joo Park; Huiyeon Ahn; Byeonghak Moon; Kyu Hyuck Chung; Seung Min Oh
Journal:  Environ Health Toxicol       Date:  2016-05-09

10.  Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols.

Authors:  Nicolas Lebouvier; Fabrice Pagniez; Young Min Na; Da Shi; Patricia Pinson; Mathieu Marchivie; Jean Guillon; Tarek Hakki; Rita Bernhardt; Sook Wah Yee; Claire Simons; Marie-Pierre Lézé; Rolf W Hartmann; Angélique Mularoni; Guillaume Le Baut; Isabelle Krimm; Ruben Abagyan; Patrice Le Pape; Marc Le Borgne
Journal:  Pharmaceuticals (Basel)       Date:  2020-08-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.